Back

Prevalence of heart failure with preserved ejection fraction (HFpEF) and symptoms in patients with metabolic dysfunction-associated steatotic liver disease (MASLD)

30 August 2026 (13:15 - 14:00)
Organised by: Logo
Congress Presentation Part of: Innovative diagnostics and treatments in heart failure Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Manan Pareek

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

6 More presentations in this session

Presentation thumbnail
Prognostic impact of heart failure phenotype based on left ventricular ejection fraction and HFA-PEFF score after surgical or transcatheter aortic valve replacement
Doctor T. Ohmori (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Circulating ketone bodies are inversely associated with myocardial ketone body oxidative capacity in human failing hearts
Mr J. Schmidt (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Ketone treatment has favourable effects on cardiac energy metabolism in patients with chronic heart failure
Doctor N. Abild Jespersen (Aarhus, DK)
Abstract Slides Video
Presentation thumbnail
Atrial cardiomyocytes lose contractile reserve with increased frequency and adrenergic stimulation in a murine HFpEF model
Mr H. Zhang (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
From guidelines to precision care: a personalised approach to heart failure management using heterogeneous treatment effects
Mrs H. Ghaem Sigarchian (Geel, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Innovative diagnostics and treatments in heart failure

The Event

Event poster

ESC Congress 2026

30 August 2026 13:15 CET
You may be interested in
thumbnail
Congress Presentation
Cardiovascular-kidney-metabolic (CKM) syndrome stage is associated with impaired cardiac structure/function and increased symptom burden in patients with MASLD
30 August 2026
thumbnail
Congress Presentation
Occurrence of echocardiographic indicators consistent with heart failure with preserved ejection fraction in everyday clinical settings
13 May 2024
thumbnail
Congress Presentation
Glucagon-like peptide-1 receptor agonists and outcomes in heart failure with preserved ejection fraction and obesity: a real-world systematic review and meta-analysis of observational studies
28 August 2026
thumbnail
Congress Presentation
Hepato-cardiac crosstalk: mechanisms linking liver to cardiovascular dysfunction
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources